What is in the Myopathy Literature?

Area of Science:

• Neurology
• Rheumatology
• Genetics

Background:

• Statin-associated muscle symptoms are common but often misattributed.
• Autoimmune myopathies and genetic myopathies require specific diagnostic and management strategies.
• Advances in muscle imaging and biochemical markers aid in diagnosing muscle disorders.

Purpose of the Study:

• To provide an update on the diagnosis and management of various muscle disorders.
• To highlight recent findings in statin-induced myopathies and autoimmune myopathies.
• To review current diagnostic tools and therapeutic options for myopathies.

Main Methods:

• Literature review of recent studies on muscle disorders.
• Analysis of incidence and features of statin-associated muscle symptoms.
• Discussion of diagnostic utility of muscle imaging (ultrasound, MRI) and biomarkers (serum aldolase).

Main Results:

• Statin myopathy features and potential mitochondrial dysfunction are detailed.
• Autoimmune myopathies, including immune-mediated necrotizing myopathy and myositis, are discussed.
• Elevated serum aldolase with normal creatine kinase and rhabdomyolysis evaluation are addressed.
• Muscle imaging findings in inherited and inflammatory myopathies are presented.
• Treatment options for nondystrophic myotonias and fatty acid oxidation disorders are reviewed.

Conclusions:

• Accurate diagnosis of muscle symptoms requires careful consideration of statin use and autoimmune processes.
• Muscle imaging and specific biomarkers enhance diagnostic accuracy for myopathies.
• Current therapeutic strategies offer improved management for various muscle conditions.